Corporate Tech Investors

Lilly Asia Ventures

Lilly Asia Ventures is a corporate VC investing group that partners with companies that are a good strategic fit.

Venture Investor Overview

Venture Investor
Lilly Asia Ventures
Status
Active
Investor Type
Corporate
Activity Level
Funds Raised
Industry Focus
Biopharmaceutical
Healthcare IT
Healthcare Services
Medical Devices & Instruments

Contact Information

Contact
Yi Shi
Title
Managing Director
Mailing Address
2730 Sand Hill Rd. 130
Menlo Park, CA 94025
USA
Phone
Undisclosed
Email Address
Not Recorded

Background Information

Overview
Lilly Asia Ventures makes venture capital investments in the life sciences and healthcare sectors in Asia, particularly China. We are affiliated with Eli Lilly and Company, a fortune 500 company and one of the most globalized and innovative pharmaceutical companies in the world. Such affiliation allows us to provide proprietary capital, industry expertise, and global resources to our portfolio companies to accelerate their growth.
Profile
Lilly Asia Ventures LinkedIn Company Profile
Social Media
Lilly Asia Ventures Company Twitter Account
Company News
Lilly Asia Ventures News
Facebook
Lilly Asia Ventures on Facebook
YouTube
Lilly Asia Ventures on YouTube
Last Transaction
3/7/2024

Transaction History

Our records indicate that Lilly Asia Ventures invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Company
Date
Amount
3/7/2024
$259,000,000
2/13/2024
$112,000,000
10/10/2023
$57,000,000
10/3/2023
$35,000,000
9/21/2023
Unknown
8/9/2023
$200,000,000
3/27/2023
$155,000,000
2/1/2023
$50,000,000
1/20/2023
$46,000,000
9/2/2022
$50,000,000
8/1/2022
$22,000,000
7/4/2022
$150,000,000
9/14/2021
$75,000,000
8/5/2021
$265,000,000
6/11/2021
$107,500,000
3/30/2021
$40,000,000
1/6/2021
$87,000,000
10/1/2020
$30,000,000
9/30/2020
$147,000,000
8/26/2020
$115,000,000
9/16/2019
$37,000,000
5/23/2019
$40,000,000
3/13/2019
$70,000,000
2/19/2019
$115,500,000
2/7/2019
$15,000,000
2/5/2019
$10,000,000
11/14/2018
$93,000,000
11/13/2018
$70,000,000
10/31/2018
$80,000,000
10/22/2018
$80,000,000
9/29/2018
$80,000,000
8/9/2018
Unknown
7/26/2018
$133,000,000
6/8/2018
$65,000,000
5/15/2018
$85,000,000
5/3/2018
$25,000,000
4/20/2018
$35,000,000
3/29/2018
$70,000,000
3/29/2018
$60,000,000
9/8/2017
$92,700,000
7/13/2017
$63,000,000
6/1/2017
$19,000,000
5/24/2017
$45,000,000
10/18/2016
$30,000,000
9/28/2016
$18,000,000
8/24/2016
$20,000,000
7/26/2016
$14,000,000
1/15/2016
$10,000,000
1/7/2016
$67,000,000
11/10/2015
$30,000,000
9/22/2015
$15,000,000
5/26/2014
$26,600,000

 


Investor Contacts

Title
Name
Email & Social
Managing Director
Yi Shi
  Yi Shi LinkedIn Profile  Yi Shi Twitter Account  Yi Shi News  Yi Shi on Facebook
Managing Partner
Michael Zhang
  Michael Zhang LinkedIn Profile  Michael Zhang Twitter Account  Michael Zhang News  Michael Zhang on Facebook

 


Funds

No fund closings have been recorded for this company.

 


Portfolio Companies

Lilly Asia Ventures has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Tech Company

 

 


 

 

Browse more corporate investors:

Ligand Pharmaceuticals | Lilly Ventures

 

Share this article

 


About Our Database of Corporate Tech Investors

Our corporate equity investment data comes from VentureDeal.com, a leading provider of corporate tech investing transaction data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary